T. Shaw3, Lincoln, Ishani Hariprasad, Leonard V. Messner, Chandani A. Bansal, Sidney A. Schechet, and Janette Pérez. 2022. “Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature”. BOHR International Journal of Current Research in Optometry and Ophthalmology 1 (1):74–79. https://doi.org/10.54646/bijcroo.2022.19.